Enter assignee name

EPO Patents = 1

Forward Citations = 48

Loading Chart...

9 inventors (with patents filed for the assignee):

Alexis Howerton (7 out of 7 patents)

Hal Gerber (7 out of 7 patents)

Michael Guanran Huang (6 out of 11 patents)

4. Christopher Barnes (3 out of 3 patents)

5. Mustafa Noor (2 out of 2 patents)

6. David Karpf (2 out of 2 patents)

7. Lu Wang (1 out of 1 patent)

8. Ashokraj Rajagopal (1 out of 1 patent)

9. Dasharatha Reddy (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12115166 - Corticotropin releasing factor receptor antagonists (2024-10-15),

2. 12098152 - Methods and compositions for treating polycystic ovary syndrome (2024-09-24),

3. 11858932 - Methods and compositions for treating polycystic ovary syndrome (2024-01-02),

4. 11708372 - Crystalline composition of tildacerfont and methods of use and preparation thereof (2023-07-25),

5. 11351177 - Corticotropin releasing factor receptor antagonists (2022-06-07),

6. 11344557 - Corticotropin releasing factor receptor antagonists (2022-05-31),

7. 11311549 - Corticotropin releasing factor receptor antagonists (2022-04-26),

8. 11304950 - Methods for treating testicular and ovarian adrenal rest tumors (2022-04-19),

9. 11007201 - Corticotropin releasing factor receptor antagonists (2021-05-18),

10. 10849908 - Corticotropin releasing factor receptor antagonists (2020-12-01),

Spruce Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapies for rare endocrine disorders. The company's lead product candidate, tildacerfont, is being evaluated in Phase 2 clinical trials for the treatment of classic congenital adrenal hyperplasia. Spruce is dedicated to improving the lives of patients with rare and underserved endocrine conditions.

This text is generated by artificial intelligence and may not be accurate.